| 摘要 |
Myocardial infarction is prevented entirely or its severity is reduced in patients subject to the same by administering to such patients after occurrence of coronary occlusion and prior to the setting in of the myocardial infarction of a myocardial infarction preventing effective amount of a beta-(2- or 4-pyridyl-alkyl)-amine or a non-toxic acid addition salt thereof. Such administration acts to help prevent the onset of the myocardial infarction or acts to reduce the size of any formed infarct. |
